Lantern Pharma News

This is selected news for Lantern Pharma, which is filed under Sectors / Healthtech. There are 451 news items for this page. Lantern Pharma is occasionally combined with Panna Sharma, BenevolentAI and Biovista in news items.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
9/23/2022 Lantern Pharma to Present Positive Preclinical Data on the Efficacy of LP-284 for Mantle Cell Lymphoma at the Society of Hematologic Oncology Annual Meeting | Business Wire
DALLAS- Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR ¬AE artificial intelligence ("A.I.") and machine learning (‚AuM.L.‚Au) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that it will present preclinical data on the potency of ...
Business Wire
9/23/2022 Lantern Pharma to Present Positive Preclinical Data on the Efficacy of LP-284 for Mantle Cell Lymphoma at the Society of Hematologic Oncology Annual Meeting
DALLAS--(BUSINESS WIRE)--Sep 23, 2022-- Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR ¬AE artificial intelligence ("A.I.") and machine learning (‚AuM.L.‚Au) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that it will present preclinical ...
Business Wire
9/23/2022 Lantern Pharma to Present Positive Preclinical Data on the Efficacy of LP-284 for Mantle Cell Lymphoma at the Society of Hematologic Oncology Annual Meeting
DALLAS, September 23, 2022 --( BUSINESS WIRE )-- Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR ¬AE artificial intelligence ("A.I.") and machine learning ("M.L.") platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that it will present preclinical data ...
Yahoo News
9/23/2022 Lantern Pharma to Present Positive Preclinical Data on the Efficacy of LP-284 for Mantle Cell Lymphoma at the Society of Hematologic Oncology Annual Meeting
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR ¬AE artificial intelligence ("A.I.") and machine learning (‚AuM.L.‚Au) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that it will present preclinical data on the potency of Lantern ...
inyoregister.com
9/23/2022 Lantern Pharma to Present Positive Preclinical Data on the Efficacy of LP-284 for Mantle Cell Lymphoma at the Society of Hematologic Oncology Annual Meeting
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR ¬AE artificial intelligence ("A.I.") and machine learning (‚AuM.L.‚Au) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that it will present preclinical data on the potency of Lantern ...
post-gazette.com
9/23/2022 Lantern Pharma to Present Positive Preclinical Data on the Efficacy of LP-284 for Mantle Cell Lymphoma at the Society of Hematologic Oncology Annual Meeting | Insider Tracking insidertracking.com
9/23/2022 Lantern Pharma to Present Positive Preclinical Data on the Efficacy of LP-284 for Mantle Cell Lymphoma at the Society of Hematologic Oncology Annual Meeting pharmaceuticaldaily.com
9/23/2022 Stock Market | Finance azcentral.com
9/23/2022 The Newport Daily Express newportvermontdailyexpress.com
9/23/2022 Stock Market | observernewsonline.com observernewsonline.com
9/19/2022 Lantern Pharma to Host Virtual KOL Webinar on the Treatment of Pediatric Cancers During Childhood Cancer Awareness Month, featuring Peter Houghton, Ph.D. | Business Wire Business Wire
9/19/2022 Stock Market | mammothtimes.com mammothtimes.com
9/19/2022 Stock Market | bigspringherald.com bigspringherald.com
9/19/2022 Lantern Pharma to Host Virtual KOL Webinar on the Treatment of Pediatric Cancers During Childhood Cancer Awareness Month, featuring Peter Houghton, Ph.D. Yahoo News
9/17/2022 Lantern Pharma Inc. (NASDAQ:LTRN) Shares Sold by Sanders Morris Harris LLC - Mayfield Recorder Mayfield Recorder
9/17/2022 Sanders Morris Harris LLC Decreases Stock Holdings in Lantern Pharma Inc. (NASDAQ:LTRN) modernreaders.com
9/17/2022 Lantern Pharma Inc. (NASDAQ:LTRN) Shares Sold by Sanders Morris Harris LLC Dakota Financial News
9/15/2022 Other news to note for Sept. 15, 2022 BioWorld
9/14/2022 Lantern Pharma to Present Positive Preclinical Data on the Efficacy of LP-184 for Pancreatic Cancer at the AACR Special Conference for Pancreatic Cancer Yahoo News
9/14/2022 Lantern Pharma to Present Positive Preclinical Data on the Efficacy of LP-184 for Pancreatic Cancer at the AACR Special Conference for Pancreatic Cancer inyoregister.com
9/14/2022 Lantern Pharma to Present Positive Preclinical Data on the Efficacy of LP-184 for Pancreatic Cancer at the AACR Special Conference for Pancreatic Cancer buffalonews.com
9/14/2022 2022-09-14 | NDAQ:LTRN | Press Release | Lantern Pharma Inc. stockhouse.com
9/14/2022 Lantern Pharma to Present Positive Preclinical Data on the Efficacy of LP-184 for Pancreatic Cancer at the AACR Special Conference for Pancreatic Cancer pharmaceuticaldaily.com
9/14/2022 Stock Market | FinancialContent Business Page financialcontent.com
9/3/2022 Lantern Pharma (NASDAQ:LTRN) Shares Down 6.3% - Stock Observer thestockobserver.com